Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Sponsor: Clear Scientific, Inc.
Summary
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).
Official title: A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-02-05
Completion Date
2026-09-11
Last Updated
2026-01-12
Healthy Volunteers
No
Interventions
Methamphetamine
Methamphetamine HCl for intravenous administration
Sterile Saline
Sterile Saline for intravenous administration
CS-1103
CS-1103 for intravenous administration
Locations (1)
California Clinical Trials Medical Group
Glendale, California, United States